2016 Q1 Form 10-K Financial Statement
#000119312516499264 Filed on March 10, 2016
Income Statement
Concept | 2016 Q1 | 2015 | 2014 Q4 |
---|---|---|---|
Revenue | $396.0K | $1.201M | $0.00 |
YoY Change | 277.14% | 241.19% | |
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | $2.410M | $4.530M | $1.097M |
YoY Change | 85.38% | 160.94% | 317.11% |
% of Gross Profit | |||
Research & Development | $3.430M | $7.187M | $619.0K |
YoY Change | 273.64% | 9.06% | 56.71% |
% of Gross Profit | |||
Depreciation & Amortization | $58.00K | $232.0K | $0.00 |
YoY Change | -6.45% | -32.16% | |
% of Gross Profit | |||
Operating Expenses | $5.839M | $24.22M | $1.716M |
YoY Change | 104.73% | 156.88% | 160.79% |
Operating Profit | -$5.443M | -$23.02M | -$1.716M |
YoY Change | 98.14% | 153.61% | 160.79% |
Interest Expense | $223.0K | $953.0K | $0.00 |
YoY Change | 21.2% | -93.76% | |
% of Operating Profit | |||
Other Income/Expense, Net | -$3.000K | -$44.00K | $4.000K |
YoY Change | 1366.67% | ||
Pretax Income | -$5.670M | -$26.17M | -$1.710M |
YoY Change | 265.81% | 291.14% | 159.09% |
Income Tax | $0.00 | ||
% Of Pretax Income | |||
Net Earnings | -$5.669M | -$26.17M | -$1.712M |
YoY Change | 214.42% | 8.38% | 160.18% |
Net Earnings / Revenue | -1431.57% | -2178.77% | |
Basic Earnings Per Share | |||
Diluted Earnings Per Share | -$3.831M | -$32.31M | -$9.000M |
COMMON SHARES | |||
Basic Shares Outstanding | 14.52M shares | 4.804M shares | |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2016 Q1 | 2015 | 2014 Q4 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $14.75M | $18.90M | $11.57M |
YoY Change | 42.37% | 82.43% | 115600.0% |
Cash & Equivalents | $14.75M | $18.90M | $451.0K |
Short-Term Investments | |||
Other Short-Term Assets | $206.0K | $1.560M | $50.00K |
YoY Change | 80.7% | 875.0% | -80.0% |
Inventory | |||
Prepaid Expenses | |||
Receivables | |||
Other Receivables | |||
Total Short-Term Assets | $15.76M | $20.46M | $831.0K |
YoY Change | 49.81% | 94.49% | 219.62% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $783.0K | $690.0K | $470.0K |
YoY Change | 398.73% | 331.25% | |
Goodwill | $15.94M | ||
YoY Change | |||
Intangibles | $7.534M | ||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $200.0K | $250.0K | |
YoY Change | |||
Total Long-Term Assets | $24.46M | $24.41M | $720.0K |
YoY Change | 15478.98% | 15156.25% | -38.46% |
TOTAL ASSETS | |||
Total Short-Term Assets | $15.76M | $20.46M | $831.0K |
Total Long-Term Assets | $24.46M | $24.41M | $720.0K |
Total Assets | $40.22M | $44.87M | $1.551M |
YoY Change | 276.62% | 320.13% | 8.46% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $1.272M | $1.090M | $216.0K |
YoY Change | -73.98% | ||
Accrued Expenses | $1.060M | $1.490M | $3.544M |
YoY Change | 65.63% | 132.81% | 4962.86% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | $1.682M | $1.030M | |
YoY Change | |||
Total Short-Term Liabilities | $4.014M | $3.610M | $43.46M |
YoY Change | 532.13% | 464.06% | 2288.08% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $5.069M | $5.690M | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | $10.00K | $10.00K | |
YoY Change | |||
Total Long-Term Liabilities | $5.069M | $5.700M | $0.00 |
YoY Change | |||
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $4.014M | $3.610M | $43.46M |
Total Long-Term Liabilities | $5.069M | $5.700M | $0.00 |
Total Liabilities | $12.05M | $12.27M | $44.77M |
YoY Change | 1783.28% | 1817.19% | 2360.0% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$133.8M | -$101.9M | |
YoY Change | 1191.24% | ||
Common Stock | $161.9M | $23.14M | |
YoY Change | 693.64% | ||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $28.17M | $32.61M | -$78.79M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $40.22M | $44.87M | $1.551M |
YoY Change | 276.62% | 320.13% | 8.46% |
Cashflow Statement
Concept | 2016 Q1 | 2015 | 2014 Q4 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$5.669M | -$26.17M | -$1.712M |
YoY Change | 214.42% | 8.38% | 160.18% |
Depreciation, Depletion And Amortization | $58.00K | $232.0K | $0.00 |
YoY Change | -6.45% | -32.16% | |
Cash From Operating Activities | -$4.080M | -$12.47M | -$1.310M |
YoY Change | 251.72% | 131.35% | 495.45% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $73.00K | $266.0K | $0.00 |
YoY Change | 284.21% | -6.67% | |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $9.670M | ||
YoY Change | |||
Cash From Investing Activities | -$70.00K | $9.410M | $0.00 |
YoY Change | 16.67% | -5981.25% | |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 0.000 | 21.52M | 0.000 |
YoY Change | 6421.21% | -100.0% | |
NET CHANGE | |||
Cash From Operating Activities | -4.080M | -12.47M | -1.310M |
Cash From Investing Activities | -70.00K | 9.410M | 0.000 |
Cash From Financing Activities | 0.000 | 21.52M | 0.000 |
Net Change In Cash | -4.150M | 18.46M | -1.310M |
YoY Change | 240.16% | -453.64% | 1537.5% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$4.080M | -$12.47M | -$1.310M |
Capital Expenditures | $73.00K | $266.0K | $0.00 |
Free Cash Flow | -$4.153M | -$12.74M | -$1.310M |
YoY Change | 252.25% | 124.42% | 495.45% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2015Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
1000 | |
CY2015Q4 | us-gaap |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Tax Liabilities Noncurrent
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent
|
2959000 | |
CY2015Q4 | us-gaap |
Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
|
43783000 | |
CY2016Q1 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
14516010 | shares |
CY2015Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2015Q2 | dei |
Entity Public Float
EntityPublicFloat
|
139127808 | |
CY2012Q4 | us-gaap |
Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
|
27556000 | |
CY2013Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-74840000 | |
CY2013Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
1026000 | |
CY2013Q4 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
1377000 | |
CY2013Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1425000 | |
CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
732823 | shares |
CY2014Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
233500000 | shares |
CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
2.10 | |
CY2014Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
188625 | shares |
CY2014Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2014 | us-gaap |
Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
|
25000 | |
CY2014Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
188625 | shares |
CY2014Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
23142000 | |
CY2014Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
55000 | |
CY2014Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-78794000 | |
CY2014Q4 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
18000 | |
CY2014Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
1086000 | |
CY2014Q4 | us-gaap |
Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
|
39703000 | |
CY2014Q4 | us-gaap |
Accrued Vacation Current
AccruedVacationCurrent
|
31000 | |
CY2014Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
216000 | |
CY2014Q4 | us-gaap |
Accrued Salaries Current
AccruedSalariesCurrent
|
60000 | |
CY2014Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
3544000 | |
CY2014Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-101936000 | |
CY2014Q4 | us-gaap |
Liabilities
Liabilities
|
44772000 | |
CY2014Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
1551000 | |
CY2014Q4 | us-gaap |
Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
|
32506000 | |
CY2014Q4 | us-gaap |
Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
|
39703000 | |
CY2014Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
2527000 | |
CY2014Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
43463000 | |
CY2014Q4 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
3338000 | |
CY2014Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
32506000 | |
CY2014Q4 | us-gaap |
Assets
Assets
|
1551000 | |
CY2014Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
470000 | |
CY2014Q4 | us-gaap |
Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
|
250000 | |
CY2014Q4 | us-gaap |
Assets Current
AssetsCurrent
|
831000 | |
CY2014Q4 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
28252000 | |
CY2014Q4 | us-gaap |
Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
|
97000 | |
CY2014Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
571000 | |
CY2014Q4 | us-gaap |
Prepaid Insurance
PrepaidInsurance
|
36000 | |
CY2014Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
380000 | |
CY2014Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
451000 | |
CY2014Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
2997000 | |
CY2014Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
|
2112000 | |
CY2014Q4 | us-gaap |
Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
|
193000 | |
CY2014Q4 | pulm |
Preferred Stock Warrant Liability
PreferredStockWarrantLiability
|
1309000 | |
CY2014Q4 | pulm |
Accrued Clinical And Consulting Current
AccruedClinicalAndConsultingCurrent
|
16000 | |
CY2014Q4 | pulm |
Accrued Legal And Patent Current
AccruedLegalAndPatentCurrent
|
44000 | |
CY2014Q4 | pulm |
Debt Instrument Accretion Of Debt Discount
DebtInstrumentAccretionOfDebtDiscount
|
13401000 | |
CY2014Q4 | pulm |
Prepaid Clinical Trials
PrepaidClinicalTrials
|
54000 | |
CY2014Q4 | pulm |
Deferred Tax Assets Deferred Expense Capitalized Startup
DeferredTaxAssetsDeferredExpenseCapitalizedStartup
|
1571000 | |
CY2014Q4 | pulm |
Debt Instrument Unamortized Discount Increase From Additional Issuance During Period
DebtInstrumentUnamortizedDiscountIncreaseFromAdditionalIssuanceDuringPeriod
|
12042000 | |
CY2015Q1 | us-gaap |
Bridge Loan
BridgeLoan
|
350000 | |
CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
|
665202 | shares |
CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
2316569 | shares |
CY2015Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
8.59 | |
CY2015Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
14745754 | shares |
CY2015Q4 | us-gaap |
Accrued Vacation Current
AccruedVacationCurrent
|
45000 | |
CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
|
8.48 | |
CY2015Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
899466 | shares |
CY2015Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
14745754 | shares |
CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
5.10 | |
CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
|
2193073 | shares |
CY2015Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
|
632000 | |
CY2015Q4 | us-gaap |
Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
|
611000 | |
CY2015Q4 | us-gaap |
Deferred Tax Liabilities
DeferredTaxLiabilities
|
2958000 | |
CY2015Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
160708000 | |
CY2015Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
25000 | |
CY2015Q4 | us-gaap |
Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
|
3271000 | |
CY2015Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
32606000 | |
CY2015Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
|
698000 | |
CY2015Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
5692000 | |
CY2015Q4 | us-gaap |
Deferred Rent Credit
DeferredRentCredit
|
4000 | |
CY2015Q4 | us-gaap |
Deposits Money Market Deposits
DepositsMoneyMarketDeposits
|
50000 | |
CY2015Q4 | us-gaap |
Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
|
11000 | |
CY2015Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
1026000 | |
CY2015Q4 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
1029000 | |
CY2015Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1090000 | |
CY2015Q4 | us-gaap |
Accrued Salaries Current
AccruedSalariesCurrent
|
673000 | |
CY2015Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
1486000 | |
CY2015Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-128103000 | |
CY2015Q4 | us-gaap |
Liabilities
Liabilities
|
12267000 | |
CY2015Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
44873000 | |
CY2015Q4 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
248000 | |
CY2015Q4 | us-gaap |
Assets Current
AssetsCurrent
|
20462000 | |
CY2015Q4 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
38179000 | |
CY2015Q4 | us-gaap |
Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
|
92000 | |
CY2015Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
1937000 | |
CY2015Q4 | us-gaap |
Prepaid Insurance
PrepaidInsurance
|
220000 | |
CY2015Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
|
102689000 | |
CY2015Q4 | us-gaap |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
|
7534000 | |
CY2015Q4 | us-gaap |
Goodwill
Goodwill
|
15942000 | |
CY2015Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
|
676000 | |
CY2015Q4 | us-gaap |
Deferred Tax Liabilities Deferred Expense Capitalized Research And Development Costs
DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts
|
2958000 | |
CY2015Q4 | us-gaap |
Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
|
6721000 | |
CY2015Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
2605000 | |
CY2015Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
3605000 | |
CY2015Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
|
654000 | |
CY2015Q4 | us-gaap |
Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
|
2959000 | |
CY2015Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
1312000 | |
CY2015Q4 | us-gaap |
Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
|
31000 | |
CY2015Q4 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
|
5488000 | |
CY2015Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
43783000 | |
CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
|
1376000 | |
CY2015Q4 | us-gaap |
Assets
Assets
|
44873000 | |
CY2015Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
|
61823000 | |
CY2015Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
7534000 | |
CY2015Q4 | us-gaap |
Deferred Costs Current
DeferredCostsCurrent
|
598000 | |
CY2015Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
685000 | |
CY2015Q4 | us-gaap |
Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
|
250000 | |
CY2015Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
1560000 | |
CY2015Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
18902000 | |
CY2015Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
3290000 | |
CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
1403000 | |
CY2015Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
|
2271000 | |
CY2015Q4 | us-gaap |
Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
|
481000 | |
CY2015Q4 | pulm |
Stock And Warrant Issued During Period Value New Issues
StockAndWarrantIssuedDuringPeriodValueNewIssues
|
10000000 | |
CY2015Q4 | pulm |
Working Capital
WorkingCapital
|
16854000 | |
CY2015Q4 | pulm |
Accrued Clinical And Consulting Current
AccruedClinicalAndConsultingCurrent
|
622000 | |
CY2015Q4 | pulm |
Accrued Legal And Patent Current
AccruedLegalAndPatentCurrent
|
62000 | |
CY2015Q4 | pulm |
Debt Instrument Accretion Of Debt Discount
DebtInstrumentAccretionOfDebtDiscount
|
1617000 | |
CY2015Q4 | pulm |
Prepaid Clinical Trials
PrepaidClinicalTrials
|
169000 | |
CY2015Q4 | pulm |
Deferred Tax Assets Deferred Expense Capitalized Startup
DeferredTaxAssetsDeferredExpenseCapitalizedStartup
|
1396000 | |
CY2015Q4 | pulm |
End Of Term Fee
EndOfTermFee
|
55000 | |
CY2015Q4 | pulm |
Debt Instrument Unamortized Discount Increase From Additional Issuance During Period
DebtInstrumentUnamortizedDiscountIncreaseFromAdditionalIssuanceDuringPeriod
|
1847000 | |
CY2014 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
240000 | |
CY2014 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
196000 | |
CY2014 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-9076000 | |
CY2014 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-3000 | |
CY2014 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-24144000 | |
CY2014 | us-gaap |
Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
|
-33463000 | |
CY2014 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
3000 | |
CY2015Q4 | pulm |
Debt Discount Debt Issuance Costs Bridge Loan And Carrying Value Of Term Loan
DebtDiscountDebtIssuanceCostsBridgeLoanAndCarryingValueOfTermLoan
|
9610000 | |
CY2015Q2 | us-gaap |
Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
|
1-for-2.5 reverse stock split | |
CY2015Q2 | us-gaap |
Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
|
0.4 | pure |
CY2015Q2 | us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
-2692000 | |
CY2015Q4 | us-gaap |
Lease Expiration Date1
LeaseExpirationDate1
|
2016-12-31 | |
CY2015Q4 | us-gaap |
Lease Expiration Date1
LeaseExpirationDate1
|
2020-12-31 | |
CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
|
0.014 | pure |
CY2014 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-9166000 | |
CY2014 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-34.52 | |
CY2014 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
9993023 | shares |
CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.340 | pure |
CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
0.154 | pure |
CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
|
0.007 | pure |
CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.001 | pure |
CY2014 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
186955 | shares |
CY2014 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.0000 | pure |
CY2014 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
285000 | |
CY2014 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-6453000 | |
CY2014 | us-gaap |
Revenues
Revenues
|
352000 | |
CY2014 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
-121000 | |
CY2014 | us-gaap |
Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
|
0 | |
CY2014 | us-gaap |
Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
|
352000 | |
CY2014 | us-gaap |
Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
|
60000 | |
CY2014 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | |
CY2014 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
240000 | |
CY2014 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-211000 | |
CY2014 | us-gaap |
Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
|
40000 | |
CY2014 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-974000 | |
CY2014 | us-gaap |
Operating Expenses
OperatingExpenses
|
9428000 | |
CY2014 | us-gaap |
Interest Expense
InterestExpense
|
15276000 | |
CY2014 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-285000 | |
CY2014 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
8477000 | |
CY2014 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
6590000 | |
CY2014 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-240000 | |
CY2014 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
3000 | |
CY2014 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
2838000 | |
CY2014 | us-gaap |
Increase In Carrying Amount Of Redeemable Preferred Stock
IncreaseInCarryingAmountOfRedeemablePreferredStock
|
40000 | |
CY2014 | us-gaap |
Extinguishment Of Debt Amount
ExtinguishmentOfDebtAmount
|
7087000 | |
CY2014 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-329000 | |
CY2014 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
342000 | |
CY2014 | us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
8475000 | |
CY2014 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
342000 | |
CY2014 | us-gaap |
Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
|
0 | |
CY2014 | us-gaap |
Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock
AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock
|
40000 | |
CY2014 | pulm |
Effective Income Tax Rate Reconciliation Nondeductible Expense Interest
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseInterest
|
0.180 | pure |
CY2014 | pulm |
Effective Income Tax Rate Reconciliation Nondeductible Expense Merger Transaction Costs
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMergerTransactionCosts
|
0.000 | pure |
CY2014 | pulm |
Net Income Loss Attributable To Common Stockholders Basic And Diluted
NetIncomeLossAttributableToCommonStockholdersBasicAndDiluted
|
-6453000 | |
CY2014 | pulm |
Cash Restricted For Letter Of Credit
CashRestrictedForLetterOfCredit
|
200000 | |
CY2014 | pulm |
Conversion Of Notes Payable And Accrued Interest To Convertible Preferred Stock
ConversionOfNotesPayableAndAccruedInterestToConvertiblePreferredStock
|
7943000 | |
CY2014 | pulm |
Noncash Interest Expenses
NoncashInterestExpenses
|
15276000 | |
CY2014 | pulm |
Promissory Note Issuance Proceeds Allocated To Beneficial Conversion Feature
PromissoryNoteIssuanceProceedsAllocatedToBeneficialConversionFeature
|
2256000 | |
CY2014 | pulm |
Promissory Note Issuance Proceeds Allocated To Preferred Stock Warrants
PromissoryNoteIssuanceProceedsAllocatedToPreferredStockWarrants
|
386000 | |
CY2014 | pulm |
Adjustments To Additional Paid Capital Temporary Equity Repurchase And Financial Liabilities Extinguishment
AdjustmentsToAdditionalPaidCapitalTemporaryEquityRepurchaseAndFinancialLiabilitiesExtinguishment
|
17731000 | |
CY2014 | pulm |
Beneficial Conversion Features Related To Convertible Promissory Notes To Stockholders Equity
BeneficialConversionFeaturesRelatedToConvertiblePromissoryNotesToStockholdersEquity
|
2256000 | |
CY2014 | pulm |
Proceeds From Extinguishment Of Debt And Repurchase Of Series Preferred Stock
ProceedsFromExtinguishmentOfDebtAndRepurchaseOfSeriesPreferredStock
|
-1000 | |
CY2014 | pulm |
Warrant Extinguishment
WarrantExtinguishment
|
389000 | |
CY2014 | pulm |
Effective Income Tax Rate Reconciliation Nondeductible Expense Permanent Differences
EffectiveIncomeTaxRateReconciliationNondeductibleExpensePermanentDifferences
|
0.000 | pure |
CY2014 | pulm |
Repurchase Of Notes Payable Preferred Stock And Warrants From Related Party
RepurchaseOfNotesPayablePreferredStockAndWarrantsFromRelatedParty
|
17731000 | |
CY2015 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
CY2015 | us-gaap |
Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
|
0.009 | pure |
CY2015 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-12472000 | |
CY2015 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2015 | |
CY2015 | pulm |
Operating Loss Carryforwards Expiration Date Description
OperatingLossCarryforwardsExpirationDateDescription
|
Various dates from 2023 through 2035 | |
CY2015 | pulm |
Cash Restricted For Letter Of Credit
CashRestrictedForLetterOfCredit
|
200000 | |
CY2015 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2015 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-3.23 | |
CY2015 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
6929691 | shares |
CY2015 | dei |
Document Type
DocumentType
|
10-K | |
CY2015 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001574235 | |
CY2015 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P8Y5M16D | |
CY2015 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P6Y11M1D | |
CY2015 | dei |
Entity Filer Category
EntityFilerCategory
|
Smaller Reporting Accelerated Filer | |
CY2015 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.340 | pure |
CY2015 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <b>Concentrations of Credit Risk</b></p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> Cash is a financial instrument that potentially subjects the Company to concentrations of credit risk. For all periods presented, substantially all of the Company’s cash was deposited in an account at a single financial institution that management believes is creditworthy. The Company is exposed to credit risk in the event of default by these financial institutions for amounts in excess of the Federal Deposit Insurance Corporation insured limits. The Company maintains its cash at a high quality financial institution and has not incurred any losses to date.</p> </div> | |
CY2015 | pulm |
Share Based Compensation Arrangements By Share Based Payment Award Options Assumed In Merger Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInMergerWeightedAverageExercisePrice
|
14.07 | |
CY2015 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
0.278 | pure |
CY2015 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
|
0.006 | pure |
CY2015 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.038 | pure |
CY2015 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
|
2018 | shares |
CY2015 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
2.12 | |
CY2015 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2015 | us-gaap |
Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
|
198000 | |
CY2015 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2015 | dei |
Entity Registrant Name
EntityRegistrantName
|
Pulmatrix, Inc. | |
CY2015 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
CY2015 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
11.13 | |
CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
1632687 | shares |
CY2015 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2015-12-31 | |
CY2015 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <b>Use of Estimates</b></p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> In preparing financial statements in conformity with U.S. GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of expenses during the reporting period. Due to inherent uncertainty involved in making estimates, actual results may differ from these estimates. On an ongoing basis, the Company evaluates its estimates and assumptions. These estimates and assumptions include valuing equity securities in share-based payments, estimating fair value of equity instruments recorded as derivative liabilities, estimating the fair value of net assets acquired in business combinations, estimating the useful lives of depreciable and amortizable assets, valuation allowance against deferred tax assets, goodwill impairment, and estimating the fair value of long-lived assets to assess whether impairment charges may apply.</p> </div> | |
CY2015 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
71323 | shares |
CY2015 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-44000 | |
CY2015 | us-gaap |
Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
|
3028 | shares |
CY2015 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
8089925 | shares |
CY2015 | dei |
Trading Symbol
TradingSymbol
|
PULM | |
CY2015 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.3928 | pure |
CY2015 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P3Y1M6D | |
CY2015 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-23018000 | |
CY2015 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
17032000 | |
CY2015 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
12000 | |
CY2015 | us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
4248000 | |
CY2015 | us-gaap |
Cash Acquired From Acquisition
CashAcquiredFromAcquisition
|
9671000 | |
CY2015 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
806000 | |
CY2015 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
232000 | |
CY2015 | us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
4457000 | |
CY2015 | us-gaap |
Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
|
66000 | |
CY2015 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
232000 | |
CY2015 | pulm |
Operating Lease Agreement Amended Date
OperatingLeaseAgreementAmendedDate
|
2015-10-27 | |
CY2015 | pulm |
Increase In Deferred Tax Assets Valuation Allowance
IncreaseInDeferredTaxAssetsValuationAllowance
|
11278000 | |
CY2015 | pulm |
Share Based Compensation Arrangement By Share Based Payment Award Options Assumed In Acquisition
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInAcquisition
|
24400 | shares |
CY2015 | pulm |
Noncash Rent Expense
NoncashRentExpense
|
-21000 | |
CY2015 | pulm |
Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
|
10000000 | |
CY2015 | pulm |
Noncash Interest Expenses
NoncashInterestExpenses
|
613000 | |
CY2015 | pulm |
Conversion Of Convertible Notes And Accrued Interest Into Common Stock
ConversionOfConvertibleNotesAndAccruedInterestIntoCommonStock
|
43060000 | |
CY2015 | pulm |
Fair Value Adjustment On Derivative Liability
FairValueAdjustmentOnDerivativeLiability
|
2291000 | |
CY2015 | pulm |
Gain Loss On Conversion Of Convertible Notes
GainLossOnConversionOfConvertibleNotes
|
-1170000 | |
CY2015 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
2480000 | |
CY2015 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
1107000 | |
CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
|
2.12 | |
CY2015 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
|
P8Y4M28D | |
CY2015 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
266000 | |
CY2015 | us-gaap |
Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
|
3022000 | |
CY2015 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-26167000 | |
CY2015 | us-gaap |
Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
|
-19093000 | |
CY2015 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
151000 | |
CY2015 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-26167000 | |
CY2015 | us-gaap |
Revenues
Revenues
|
1201000 | |
CY2015 | us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
-2291000 | |
CY2015 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
35573000 | |
CY2015 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
-13000 | |
CY2015 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
4248000 | |
CY2015 | us-gaap |
Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
|
30422000 | |
CY2015 | us-gaap |
Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
|
0 | |
CY2015 | us-gaap |
Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
|
1201000 | |
CY2015 | us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
4500000 | |
CY2015 | us-gaap |
Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
|
66000 | |
CY2015 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | |
CY2015 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
5508000 | |
CY2015 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-1309000 | |
CY2015 | us-gaap |
Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
|
37000 | |
CY2015 | us-gaap |
Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1
NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1
|
20750000 | |
CY2015 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
18451000 | |
CY2015 | us-gaap |
Operating Expenses
OperatingExpenses
|
24219000 | |
CY2015 | us-gaap |
Interest Expense
InterestExpense
|
953000 | |
CY2015 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
9405000 | |
CY2015 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
21518000 | |
CY2015 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
7187000 | |
CY2015 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
1185000 | |
CY2015 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
151000 | |
CY2015 | us-gaap |
Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
|
6910000 | |
CY2015 | us-gaap |
Debt Issuance Costs
DebtIssuanceCosts
|
43000 | |
CY2015 | us-gaap |
Noncash Or Part Noncash Acquisition Value Of Assets Acquired1
NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
|
23772000 | |
CY2015 | pulm |
Effective Income Tax Rate Reconciliation Nondeductible Expense Permanent Differences
EffectiveIncomeTaxRateReconciliationNondeductibleExpensePermanentDifferences
|
0.028 | pure |
CY2015 | pulm |
Deferred Tax Assets Tax Credit Carryforwards Expiration Date Description
DeferredTaxAssetsTaxCreditCarryforwardsExpirationDateDescription
|
Various dates from 2022 through 2035 | |
CY2015 | pulm |
Effective Income Tax Rate Reconciliation Nondeductible Expense Interest
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseInterest
|
0.035 | pure |
CY2015 | pulm |
Effective Income Tax Rate Reconciliation Nondeductible Expense Merger Transaction Costs
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMergerTransactionCosts
|
0.034 | pure |
CY2015 | pulm |
Net Income Loss Attributable To Common Stockholders Basic And Diluted
NetIncomeLossAttributableToCommonStockholdersBasicAndDiluted
|
-26167000 | |
CY2015 | pulm |
Intrinsic Value Of Common Stock Warrants Outstanding
IntrinsicValueOfCommonStockWarrantsOutstanding
|
0 | |
CY2015 | pulm |
Conversion Of Bridge Notes Into Common Stock
ConversionOfBridgeNotesIntoCommonStock
|
8407000 |